LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of shareholders of Quality Systems, Inc. (“QSI” or the “Company”) (NASDAQ:QSII) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by the Company between May 26, 2011 and July 25, 2012, concerning QSI’s financial performance and prospects.

PLEASE CONTACT US AT 212-682-5340, TOLL-FREE AT 888-773-9224, OR AT SHAREHOLDERS@GLANCYLAW.COM,TO DISCUSS THIS MATTER OR OTHER POTENTIAL CLAIMS IF YOU PURCHASED QSI STOCK PRIOR TO MAY 26, 2011. IF YOU INQUIRE BY EMAIL PLEASE INCLUDE YOUR MAILING ADDRESS, TELEPHONE NUMBER AND NUMBER OF SHARES PURCHASED.

QSI develops and markets healthcare information systems that automate medical and dental practices and networks of practices in the United States. The investigation is related to a securities class action lawsuit filed in the United States District Court for the Central District of California alleging that the Company and certain of its executive officers issued a series of material misstatements or failed to disclose material facts concerning QSI's financial prospects, including its financial guidance for fiscal years 2012 and 2013.

If you purchased shares of QSI between May 26, 2011 and July 25, 2012, if you have information or would like to learn more about these claims, or if you still hold shares of QSI purchased prior to May 26, 2011 and have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Louis Boyarsky, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, Toll-Free at 888-773-9224, or contact Gregory Linkh, Esquire, of Glancy Binkow & Goldberg LLP at 122 E. 42nd Street, Suite 2920, New York, New York 10168, at 212-682-5340, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.